Skip to main navigation Skip to search Skip to main content

CD56+Bright and CD56+DIM natural killer cells in patients with chronic myelogenous leukemia (CML) demonstrate progressive decreases in number. cytotoxicity, clonogenic frequency. and proliferation on a per cell basis

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'CD56+Bright and CD56+DIM natural killer cells in patients with chronic myelogenous leukemia (CML) demonstrate progressive decreases in number. cytotoxicity, clonogenic frequency. and proliferation on a per cell basis'. Together they form a unique fingerprint.
Sort by

Keyphrases

Nursing and Health Professions

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology